SUNDAY, OCTOBER 31, 1999

08:30 - 10:30 HALL A
B4:	ULTRASOUND SCANNING FOR FETAL MALFORMATION Capsule: Ultrasound is becoming a potent tool in detection of fetal malformations - the cost-benefit, risks and indications.
	Chairpersons:	N.M. Fisk, UK A. Ludomirski, Israel E. Shalev, Israel
	08:30	SHOULD ROUTINE EXAMINATION BE PERFORMED: ONLY BY INDICATION? L. Chitty, UK
	09:00	ULTRASOUND FOR ALL - BY WHOM AND WHEN? HOW OFTEN? F. Chervenak, L.B. McCullough, New York NY, USA
	09:30	NUCHAL TRANSLUCENCY SCREENING L. Chitty, UK
	10:00	CAN WE DIMINISH THE AGE RELATED AMNIOCENTISIS RATE? R. Frydman, France
	10:30	Coffee Break
11:00 - 13:00 HALL A
B3:	CESAREAN SECTION: THE INCREASING INCIDENCE Capsule: Should we have a strategy to minimize cesarean deliveries?
	Chairpersons:	F. Chervenak, USA F. Petraglia, Italy V. Unzeitig, Czech Republic
	11:00	IS THERE AN OPTIMAL CS RATE? S. Kjos, USA
	11:25	CS FOR ALL? N.M. Fisk, UK
	11:50	WOMEN'S RIGHT - CS FOLLOWING PATIENT'S REQUEST: YES OR NO? S. Paterson-Brown, UK
	12:15	VAGINAL DELIVERY FOLLOWING 2 CS (PRO) R.H. Paul, USA
	12:40	VAGINAL DELIVERY FOLLOWING 2 CS (CON) S. Arulkumaran, UK
	13:00	L u n c h B r e a k
14:30 - 16:00 HALL A
B6:	FETAL MONITORING Capsule: After 30 years of experience, the question remains.
	Chairpersons:	D.R. Coustan, USA D. Farine, Canada M. Mazor, Israel
	14:30	IS THERE A PLACE FOR ELECTRONIC FETAL MONITORING IN THE LOW RISK PATIENT? (PRO) R.H. Paul, USA
	14:52	IS THERE A PLACE FOR ELECTRONIC FETAL MONITORING IN THE LOW RISK PATIENT? (CON) S. Arulkumaran, UK
	15:14	DOES IT INCREASE CS RATE? (PRO) R. Paul, USA
	15:36	DOES IT INCREASE CS RATE? (CON) S. Arulkumaran, UK
	16:00	Coffee Break
08:30 - 10:30 HALL B
A7:	INCREASING SUCCESS RATE IN IVF Capsule: Although technology improved, the questions still remain.
	Chairpersons:	A. Hazout, France N. Laufer, Israel P. Ventruba, Czech Republic
	08:30	IS EMBRYO TRANSFER TECHNIQUE IMPORTANT? R. Frydman, France
	08:54	THE ROLE OF HYSTEROSCOPY PRIOR TO IVF TREATMENT (IS HSG ENOUGH?) J.E. Hamou, France
	09:18	HYDROSALPINX IN IVF - DOES IT MATTER? A. Strandell, Sweden
	09:42	PROTEIN-FREE MEDIUM FOR TRANSFER D.K. Gardner, USA
	10:06	SELECTING EMBRYOS FOR TRANSFER FOLLOWING GENETIC INVESTIGATION A.O. Trounson, Australia
	10:30	Coffee Break
11:00 - 13:00 HALL B
A8:	REPEATED PREGNANCY LOSS Capsule: The definition, work-up and treatment are controversial. Does anything help?
	Chairpersons:	A. Pellicer, Spain R.D. Kempers, USA T. Gurgan, Turkey
	11:00	DEFINITION AND ETIOLOGY OF RECURRENT SPONTANEOUS ABORTION R.F. Casper, Canada
	11:20	IS INVESTIGATION IMPORTANT - STARTING WHEN? S.H. Daya, Canada
	11:40	LUTEAL PHASE DEFECT AND SUPPORTIVE MEASUREMENTS - DOES IT HELP? J. Walker, UK
	12:00	CRITICAL APPRAISALS OF IMMUNOLOGIC TREATMENT (PRO) H.J.A. Carp, Israel
	12:20	CRITICAL APPRAISALS OF IMMUNOLOGIC TREATMENT (CON) J. Walker, UK
	12:40	DOES ANY TREATMENT HELP? ROLE OF IV IMMUNO-GROBULIN S.H. Daya, Canada
	13:00	Lunch Break
13:00 - 14:30 HALL B
LS:	Lunch Session CONTROVERSIES IN REPRODUCTIVE MEDICINE Capsule: Tissue specific hormones, GnRH-antagonists, Male HRT and innovative hormonal contraception; needs, possibilities, advantages. Sponsored by: Organon
	Chairpersons:	B.C. Tarlatzis, Greece J. Kahn, Norway
	13:00	NEW CONTRACEPTIVES ARE NEEDED H.J.T. Coelingh Bennink, The Netherlands
	13:20	GnRH ANTAGONISTS ARE SUPERIOR TO GnRH AGONISTS IN IVF P. Bouchard, France
	13:40	TISSUE SPECIFIC HORMONES ARE SUPERIOR TO ESTROGENS FOR FEMALE HRT M.E. Birkhauser, Switzerland
	14:00	MANY AGEING MALES REQUIRE ANDROGEN SUBSTITUTION B. Lunenfeld, Israel
14:30 - 16:00 HALL B
MALE:	MALE INFERTILITY Capsule: ICSI seems to be the ultimate treatment for male infertility
	Chairpersons:	B. Lunenfeld, Israel M.A. Aboulghar, Egypt C. Chillik, Argentina
	14:30	IS ANDROLOGY PASSE? F. Comhaire, Belgium
	14:48	VARICOCCELECTOMY - PRO J.L.H. Evers, The Netherlands
	15:06	VARICOCCELECTOMY - CON F. Comhaire, Belgium
	15:24	MALE FSH IN THE ERA OF ICSI D. Feldberg, Israel
	15:42	ARE THERE FACTORS PREDICTING THE SUCCESS OF SPERM RECOVERY DURING MESA-TESE PROCEDURE? K. Koci, Czech Republic
	16:00	Coffee Break
16:30 - 18:00 HALL B
H4:	INFERTILITY HRT AND ONCOLOGY Capsule: Fear of cancer decrease compliance.
	Chairpersons:	Y. Insler, Israel T. Makino, Japan Z. Shoham, Israel
	16:30	INDUCTION OF OVULATION AND OVARIAN CANCER - IS THERE AN ASSOCIATION? B. Lunenfeld, Israel
	16:52	CRYOPRESERVATION OF OVARIAN TISSUE IN CANCER PATIENTS R.G. Gosden, UK
	17:14	WHAT CAN WE EXPECT FROM THAWING? A.O. Trounson, Australia
	17:38	THE CURRENT ROLE OF HRT IN THE VARIOUS MALIGNANCIES R. Sands, UK
08:30 - 10:30 HALL C
D1:	SERM Capsule: SERMs for the prevention of osteoporosis: How strong is the evidence? Sponsored by: Eli Lilly & Co.
	Chairpersons:	C. Gennari, Italy
	08:30	EVIDENCE BASED CLINICAL EFFECTS OF SERMs M. Draper, USA
	09:00	HOW MUCH DO WE KNOW ABOUT THE EFFICACY OF RALOXIFENE VS HRT IN OSTEOPOROSIS TREATMENT? I. Vered, Israel
	09:30	RALOXIFENE VS HRT IN THE BREAST TISSUE W. Urdl, Austria
	10:00	COMPLIANCE AND QUALITY OF LIFE ISSUES: RALOXIFENE VS HRT D. Hochner, Israel
	10:30	Coffee Break
11:00 - 13:00 HALL C
C1:	HYSTERECTOMY Capsule: The most common major procedure in Gynecology is facing modification.
	Chairpersons:	T. Falcone, USA G.B. Melis, Italy V. Gomel, Canada
	11:00	DO THE DIFFERENT APPROACHES STEM FROM REAL MEDICAL ADVANTAGES OR SURGEON PREFERENCES? T. Falcone, USA
	11:24	TOTAL VS SUBTOTAL J. Donnez, Belgium
	11:48	LAPAROSCOPY VS LAPAROTOMY: SURGICAL ACCESS V. Gomel, Canada
	12:12	SHOULD WE LEAVE THE OVARIES AFTER TAH IN ENDOMETRIOSIS STATE? J.L.H. Evers, The Netherlands
	12:36	ROBOTICS VERSUS HUMAN GOLDEN FINGERS IN GYNAECOLOGIC ENDOSCOPY L. Mettler,  Germany
	13:00	Lunch Break
14:30 - 16:00 HALL C
C2:	ENDOMETRIAL ABLATION Capsule: With so many methods what is the problem?
	Chairpersons:	A.H. DeCherney, USA M. Kudela, Czech Republic T. Tulandi, Canada
	14:30	TO ABLATE VS HYSTERECTOMY T. Tulandi, Canada
	14:48	TO PRE-TREAT OR NOT PRIOR TO ABLATION? J.E. Hamou, France
	15:06	TO HEAT, MICROWAVE, CRYOABLATE OR COAGULATE? B.H. Sanders, Canada
	15:24	HYSTEROSCOPIC VS NON-HYSTEROSCOPIC ABLATION TECHNIQUE H. Fernandez, France
	15:42	MALIGNANCY FOLLOWING ABLATION. MYTH OR REALITY? A.H. DeCherney, USA
	16:00	Coffee Break
16:30 - 18:00 HALL C
C3:	ECTOPIC PREGNANCY Capsule: Early detection allows us to choose the best kind of treatment. Is there an ideal treatment?
	Chairpersons:	L. Mastroianni, Jr., USA J. Blankstein, USA T. Tulandi, Canada
	16:30	METHOTREXATE VS SALPINGOSTOMY H. Fernandez, France
	16:52	LAPAROSCOSALPINGECTOMY VS SALPINGOSTMY A.H. DeCherney, USA
	17:14	LOCAL VS SYSTEMIC MEDICAL TREATMENT M. Pansky, Israel
	17:36	CAN WE CHOOSE THE BEST MODE OF TREATMENT? A.H. DeCherney, USA